University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

A Trial of Incentives and Peer Mentors to Improve Diabetic Outcomes

Not Applicable

Completed

Conditions: Diabetes Mellitus

Interventions: Behavioral: Education
Behavioral: Incentives
Behavioral: Peer mentoring

First Posted Date: 2010-05-19

Last Posted Date: 2018-08-07

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 240

Registration Number: NCT01125969

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention

Not Applicable

Completed

Conditions: Diabetic Gastroparesis
Gastroesophageal Reflux Disease

Interventions: Other: intervention letter

First Posted Date: 2010-05-19

Last Posted Date: 2015-12-04

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 85

Registration Number: NCT01126034

Locations: 🇺🇸
University of Pennsylvania Center for Clinical Epidemiology and Biostatistics, Philadelphia, Pennsylvania, United States

H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients

Phase 4

Completed

Conditions: HIV Infections

Interventions: Biological: H1N1 vaccination

First Posted Date: 2010-04-27

Last Posted Date: 2016-07-12

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 120

Registration Number: NCT01111162

Locations: 🇺🇸
University of Pennsylvania. Clinical Trials Unit, Philadelphia, Pennsylvania, United States

Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX

Phase 2

Completed

Conditions: Substance Abuse
HIV Infections
HIV

Interventions: Drug: Oral Naltrexone
Drug: Naltrexone Implant
Behavioral: Group Drug Counseling Manual Driven

First Posted Date: 2010-04-12

Last Posted Date: 2018-11-08

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 200

Registration Number: NCT01101815

Locations: 🇷🇺
Botkin Infectious Disease Hospital, Leningrad, Russian Federation

Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland

Phase 3

Completed

Conditions: Amphetamine Dependence

Interventions: Drug: VIVITROL injection and VIVITROL Placebo Injection , 24 weeks

First Posted Date: 2010-04-09

Last Posted Date: 2018-03-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 100

Registration Number: NCT01100853

Locations: 🇮🇸
SAA National Center of Addiction Medicine, Vogur Hospital, Storhofda 45, Reykjavík, Iceland

Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis

Completed

Conditions: Interstitial Cystitis
Chronic Prostatitis

First Posted Date: 2010-04-02

Last Posted Date: 2023-08-28

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 424

Registration Number: NCT01098279

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Iowa, Iowa City, Iowa, United States

and more 5 locations

Observational Study of Control Participants for the MAPP Research Network

Completed

Conditions: Fibromyalgia
Fatigue Syndrome, Chronic
Irritable Bowel Syndrome

First Posted Date: 2010-04-02

Last Posted Date: 2014-12-10

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 615

Registration Number: NCT01098292

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Stanford University, Stanford, California, United States

and more 5 locations

Efficacy of Varenicline for Smokeless Tobacco Use in India

Phase 2

Completed

Conditions: Tobacco Use Disorder

Interventions: Drug: Varenicline
Behavioral: Counseling

First Posted Date: 2010-04-02

Last Posted Date: 2015-07-30

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 237

Registration Number: NCT01098305

Locations: 🇮🇳
All India Institute of Medical Research, New Dehli, India

Integrating Depression Services Into DM Management

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus
Depression

Interventions: Behavioral: Adherence Intervention

First Posted Date: 2010-04-02

Last Posted Date: 2012-03-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 182

Registration Number: NCT01098253

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Rhodiola Rosea Therapy of Major Depressive Disorder

Phase 3

Completed

Conditions: Depression

Interventions: Dietary Supplement: Herbal extract
Other: Lactose monohydrate
Drug: Sertraline

First Posted Date: 2010-04-02

Last Posted Date: 2018-02-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 58

Registration Number: NCT01098318

Locations: 🇺🇸
Depression Research Unit, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy